Heinz-Josef Lenz, MD Update on Molecular Targeted Therapies for Metastatic colorectal cancers @KeckMedUSC @MOASC_office #ColorectalCancer

Heinz-Josef Lenz, MD Update on Molecular Targeted Therapies for Metastatic colorectal cancers @KeckMedUSC @MOASC_office #ColorectalCancer

User Photo
moasc

6 months
32 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Heinz-Josef Lenz, MD Professor of Medicine and Preventive Medicine Associate Director, Clinical Sciences J Terrence Lanni Chair in Cancer Research Director, USC Center for Molecular Pathways and Drug Discovery USC / Norris Comprehensive Cancer Center outlines an Update on Molecular Targeted Therapies for Metastatic colorectal cancers including in depth conversation on Next-generation sequencing, The Colorectal Cancer Subtyping Consortium, bevacizumab, EGFR, 80405 trial, Gerlinger et al., NEJM 2012, Circos plot illustrating genome-wide CNA, Liquid Biopsies, KRAS, MGH GI, RAS-WT CRC, ctDNA, CALGB, SWOG 80405, Cetuximab, FOLFIRI, FOLFOXIRI, CRICKET Trial, PD-1 Blockade, Nivolumab Monotherapy, BRAF, HER2 Overexpression,Trastuzumab,HER2, ZW25, DS-8201a, BEACON CRC Phase 3, PCM-075

Sponsors:

AbbVie 

AMAG

AstraZeneca 

Bayer 

BeiGene 

Clovis Oncology

Coherus 

Daiichi-Sankyo 

Dova Pharmaceuticals 

Foundation Medicine 

Jazz Pharmaceuticals  

Merck 

Pfizer Oncology 

Puma Biotechnology 

Tempus 

Verastem oncology

Walgreens 

Up Next Autoplay